Pharmaceuticals, Biotechnology and Life Sciences
LP-284 is in a Phase 1 clinical trial, having been developed with guidance from Lantern’s AI platform, RADR®, as a…
Fourth quarter total revenue of $16.8 million, up 4% year-over-year Adjusted EBITDA(1) of $0.8 million, our 20th consecutive quarter of…
KEYTRUDA plus CRT is the first immunotherapy-based regimen to demonstrate a statistically significant improvement in OS in these patients RAHWAY,…
HORSHAM, Pa.–(BUSINESS WIRE)–#clinicaltrials–Myonex, a leading global clinical trial supply company, has reached an agreement with the owners of Creapharm Group…
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel…
Breyanzi offers a personalized treatment option delivered as a one-time infusion that provides deep and durable responses for patients with…
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic…
Initiated confirmatory Phase 3 RAMP 301 trial evaluating avutometinib and defactinib combination in recurrent low-grade serous ovarian cancer; on track…
PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active lupus nephritis actively enrolling; reiterating guidance of topline data…
FDA Oncologic Drugs Advisory Committee voted 12 to 2 in favor of the clinical benefit/risk profile of imetelstat based on…